Ertilav M - Search Results

1

The effects of colchicine on the progression and regression of encapsulating peritoneal sclerosis.

Bozkurt D, Bicak S, Sipahi S, Taskin H, Hur E, Ertilav M, Sen S, Duman S. Bozkurt D, et al. Among authors: ertilav m. Perit Dial Int. 2008 Nov;28 Suppl 5:S53-7. Perit Dial Int. 2008. PMID: 19008543

2

What does peritoneal thickness in peritoneal dialysis patients tell us?

Duman S, Ozbek SS, Gunay ES, Bozkurt D, Asci G, Sipahi S, Kirçelli F, Ertilav M, Ozkahya M, Ok E. Duman S, et al. Among authors: ertilav m. Adv Perit Dial. 2007;23:28-33. Adv Perit Dial. 2007. PMID: 17886598

3

Effects of everolimus as an antiproliferative agent on regression of encapsulating peritoneal sclerosis in a rat model.

Duman S, Bozkurt D, Sipahi S, Sezak M, Ozkan S, Ertilav M, Sen S, Ok E. Duman S, et al. Among authors: ertilav m. Adv Perit Dial. 2008;24:104-10. Adv Perit Dial. 2008. PMID: 18986012

4

The effects of renin-angiotensin system inhibition on regression of encapsulating peritoneal sclerosis.

Bozkurt D, Cetin P, Sipahi S, Hur E, Nar H, Ertilav M, Sezak M, Duman S. Bozkurt D, et al. Among authors: ertilav m. Perit Dial Int. 2008 Nov;28 Suppl 5:S38-42. Perit Dial Int. 2008. PMID: 19008539

5

Does immunosuppressive treatment ameliorate morphology changes in encapsulating peritoneal sclerosis?

Bozkurt D, Sipahi S, Cetin P, Hur E, Ozdemir O, Ertilav M, Sen S, Duman S. Bozkurt D, et al. Among authors: ertilav m. Perit Dial Int. 2009 Feb;29 Suppl 2:S206-10. Perit Dial Int. 2009. PMID: 19270219

6

A novel angiogenesis inhibitor, sunitinib malate, in encapsulating peritoneal sclerosis.

Bozkurt D, Sarsik B, Hur E, Ertilav M, Karaca B, Timur O, Bicak S, Akcicek F, Duman S. Bozkurt D, et al. Among authors: ertilav m. J Nephrol. 2011 May-Jun;24(3):359-65. doi: 10.5301/JN.2011.6257. J Nephrol. 2011. PMID: 21240876

7

Octreotide lessens peritoneal injury in experimental encapsulated peritoneal sclerosis model.

Ertilav M, Hur E, Bozkurt D, Sipahi S, Timur O, Sarsik B, Akcicek F, Duman S. Ertilav M, et al. Nephrology (Carlton). 2011 Aug;16(6):552-7. doi: 10.1111/j.1440-1797.2011.01460.x. Nephrology (Carlton). 2011. PMID: 21382127

8

What does the dialysate level of matrix metalloproteinase 2 tell us?

Ertilav M, Timur O, Hür E, Bozkurt D, Nar H, Kologlu T, Sen S, Duman S. Ertilav M, et al. Adv Perit Dial. 2011;27:6-10. Adv Perit Dial. 2011. PMID: 22073820

9

Patients with failed renal transplant may be suitable for peritoneal dialysis.

Duman S, Aşçi G, Töz H, Ozkahya M, Ertilav M, Seziş M, Ok E. Duman S, et al. Among authors: ertilav m. Int Urol Nephrol. 2004;36(2):249-52. doi: 10.1023/b:urol.0000034678.84908.9b. Int Urol Nephrol. 2004. PMID: 15368705

10

Neither oxidized nor anti-oxidized low-density lipoprotein level is associated with atherosclerosis or mortality in hemodialysis patients.

Sevinc Ok E, Kircelli F, Asci G, Altunel E, Ertilav M, Sipahi S, Bozkurt D, Duman S, Ozkahya M, Toz H, Ok E. Sevinc Ok E, et al. Among authors: ertilav m. Hemodial Int. 2012 Jul;16(3):334-41. doi: 10.1111/j.1542-4758.2012.00683.x. Epub 2012 Apr 13. Hemodial Int. 2012. PMID: 22497657

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters